Search Results for "Abcam Email"
Original Source: Abcam
Abcam is a producer and distributor of research-grade antibodies and associated products, headquartered in Cambridge, UK, with a US office located in Cambridge, Massachusetts and a Japan office located in Tokyo. Our vision is to build the largest online catalog of the best antibodies in the world. Find the antibodies relevant to your research: Cancer, Cardiovascular, Chromatin, Immunology, Microbiology, Neuroscience, Nuclear Signaling, Stem Cells. With over 47,000 products in our catalog, including a g...
Matching Channels
BioPortfolio has launched a number of Facebook pages to allow our visitors to keep track with latest news, published paper and clinical trials by lead biotechnology and healthcare topics:- &nbs...
Prostate cancer is the most common cancer in men in the UK; affecting 250,000 men. Risk factors for prostate cancer include age (average age at diagnosis is 70), a family history and a Caribbean or...
What is new in prostate cancer research and development?
Key research areas in relation to Prostate Cancer are discussed below. Brief descriptions are supported by hyperlinks to the most relevant research papers and current affairs news reports and...
Prostate cancer is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are cases of aggressive prostate ca...
Matching News
BRIEF-Abcam sees H1 sales growth of 28 pct
LONDON, Jan 22 (Reuters) - Abcam PLC : * Business has performed well despite the continued pressures on centrally
BRIEF-Abcam says will deliver continued growth
LONDON, Oct 22 (Reuters) - Abcam PLC : * Challenges faced in western markets remain a feature of our markets,
BRIEF-Abcam FY profit up 21 pct
LONDON, Sept 6 (Reuters) - Abcam PLC : * FY-revenue increased by 17.5 percent to 97.8 million STG * Trading since the year end has been in line with the board's expectations * FY-adjusted profit be...
Abcam warns on U.S. budget cuts after rise in first-half profit
March 5 (Reuters) - British biotechnology company Abcam Plc reported a 24 percent rise in first-half profit as revenue grew in all of its markets, but it warned that the latest wave of U.S. budget cu...
BRIEF-Abcam first-half pretax profit rises
LONDON, March 5 (Reuters) - Abcam PLC : * Revenues in the half year increased 28.3% to £57.3 million * Interim dividend increased by 14.8% to 1.94P per share * First half profit before tax £21.8...
Abcam Biochemicals new 2012 catalogue is launched
Bristol, UK September 2012: Abcam Biochemicals, Abcam’s new range of high purity and exceptional quality biochemical research tools announced today the launch of its new and expanded 2...
Abcam, Intrinsiq Materials Ltd., University of Bath other news
NOVEL, POTENT 5-HT7 RECEPTOR AGONIST - ABCAM LICENCES UNIVERSITY OF BARI TECHNOLOGY
LP-44, a highly potent, selective 5-HT7 agonist for unravelling neuronal functioning and neuropsychiatric disease December 18th 2012: Abcam today announced signing a licence with the University...
Matching PubMed Articles
What are the factors influencing the trustworthiness of data produced in email interviews? The main purpose of this article is to reflect on this issue by discussing two examples from my own experienc...
Providing cell phone numbers and email addresses to patients: the physician's perspective.
ABSTRACT: BACKGROUND: The provision of cell phone numbers and email addresses enhances the accessibility of medical consultations, but can add to the burden of physicians' routine clinical practice an...
OBJECTIVE: The aim of this study is to evaluate a 12-week social cognitive theory (SCT)-based email intervention designed to influence the physical activity of survivors of breast cancer. METHODS: Sev...
Adherence to Internet-delivered lifestyle interventions using multiple tailoring is suboptimal. Therefore, it is essential to invest in proactive strategies, such as periodic email prompts, to boost r...
Email interviewing: generating data with a vulnerable population.
cook c. (2011) Email interviewing: generating data with a vulnerable population. Journal of Advanced Nursing00(0), 000-000.doi: 10.1111/j.1365-2648.2011.05843.x ABSTRACT: Aims. This paper describ...
